DANCAN — Dancann Pharma A/S Cashflow Statement
0.000.00%
- DKK14.40m
- DKK14.46m
- DKK6.07m
Annual cashflow statement for Dancann Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | DAS | DAS | DAS | DAS | DAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.5 | -4.25 | -11.8 | -16.1 | -62.3 |
Non-Cash Items | 0.008 | 0.094 | 1.14 | 7.65 | 48.7 |
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.236 | -3.5 | -1.37 | -3.32 | 1.53 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.256 | -7.66 | -12 | -11.7 | -12 |
Capital Expenditures | -1.01 | -18.8 | -32.4 | -8.27 | -4.04 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | -0.322 | 0.155 | — | — |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -1.01 | -19.1 | -32.2 | -8.27 | -4.04 |
Financing Cash Flow Items | 0 | -4.67 | -0.668 | -5.74 | -1.27 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.46 | 47.9 | 30.6 | 23 | 7.33 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.19 | 21.1 | -13.6 | 3.02 | -8.74 |